-5%
Highnoon Labs
Genthro 500mg Tablets 6s
20 Tablets
Rated 4.5 out of 5 (49)
Rs. 1,275Rs. 1,340
In Stock
-18%
Abbott
Gvia M 50mg500mg Tablets
Rated 4.0 out of 5 (1)SKU HP-09302
A tablet containing Sitagliptin, Metformin, indicated for Diabetes.
Rs. 1,815Rs. 2,215-18%
You save Rs. 400
100ml Syrup
In StockSet your city for an exact delivery date
In stock at selected branches
Quantity
Gvia M 50mg500mg Tablets quantity: 1
- 100% authentic
- Free over Rs. 1,500
- Pharmacist verified
- 7-day returns
Total for 1 pack: Rs. 1,815
What it is used for: Diabetes.
Indications as listed by the manufacturer: It is indicated as: - Initial therapy in patients with type 2 diabetes mellitus to improve glycemic control when diet and exercise do not provide adequate glycemic control. As an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus inadequately controlled on Metformin HCl or Sitagliptin alone or in patients already being treated with the combination of Sitagliptin and Metformin HCl.
How it works: By increasing and prolonging active incretin levels, Sitagliptin increases insulin release and decreases glucagon levels in the circulation in a glucose-dependent manner. It is a biguanide with antihyperglycemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycemia.
Active ingredient: Sitagliptin, Metformin.
Reported side effects: Common: nausea. Uncommon: somnolence, diarrhea, upper abdominal pain and blood glucose decreased.
Known drug interactions: Digoxin , Furosemide , Nifedipine , Cationic drugs (e.g., amiloride, digoxin, morphine, procainamide, quinidine, quinine ranitidine, triamterene, trimethoprim, or vancomycin) , thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.
- Sourced through authorised distributors and checked against batch and expiry on arrival
- Dispensed by a registered pharmacist from our DRAP-licensed branches
- Free pharmacist advice on interactions and timing — call or ask at checkout
- Same-day delivery in Karachi, Lahore and Islamabad on orders placed before 6pm
For patients with type 2 diabetes mellitus, whose hyperglycemic is inadequately controlled with diet and exercise alone, the recommended starting dose of (Sitagliptin + Metformin HCl) is 50mg of Sitagliptin + 500mg of Metformin HCl twice daily. Patients may be titrated upto 50mg Sitagliptin + 1000mg of Metformin HCl twice daily. The dosage of (Sitagliptin + Metformin HCl) should be individualized on the basis of patient’s current regimen, effectiveness and tolerability while not exceeding the maximum recommended daily dose of 100mg Sitagliptin.
Active ingredient: Sitagliptin, Metformin. Labelled strength: 50mg/500mg.
- The combination of Sitagliptin and Metformin HCl is contraindicated in:- Patients with type 1 diabetes. -Patients with known hypersensitivity to Sitagliptin, Metformin HCl or any other component of the product. - Acute or chronic metabolic acidosis , including ketoacidosis, with or without coma.
- Since impaired hepatic function has been associated with some cases of lactic acidosis, Sitagliptin+Metformin HCl should generally be avoided in patients with clinical or laboratory evidence of hepatic disease.
- Patient receiving Sitagliptin+Metformin HCl in combination with a sulphonylurea or with insulin may be at risk for hypoglycemia. Therefore, a reduction in the dose of the sulphonylurea or insulin may be necessary.
- After initiation of Sitagliptin, patients should be observed carefully for signs and symptoms of pancreatitis. If pancreatitis is suspected, Sitagliptin should promptly be discontinued and appropriate management should be initiated.
- Sitagliptin+Metformin HCl are known to be substantially excreted by the kidney. Metformin HCl-related lactic acidosis increases with the degree of insufficiency of renal function, therefore, serum creatinine concentrations should be determined regularly.
Store this medicine at room temperature, away from direct light and heat.
Manufactured by Gvia Healthcare (Pvt) Ltd.. Country of origin: Germany.
4.0
Rated 4.0 out of 51 verified ratings
- 5★0%
- 4★75%
- 3★25%
- 2★0%
- 1★0%
- Komal J.Verified Purchase4 Aug 2026Rated 4.0 out of 5
Rider was on time and the item was properly bubble-wrapped. No complaints.
- Fatima S.Verified Purchase24 Jul 2026Rated 4.0 out of 5
Rider was on time and the item was properly bubble-wrapped. No complaints.
- Imran Q.Verified Purchase9 Jul 2026Rated 4.0 out of 5
Works as expected. Took about three weeks to notice a difference, which the product page had already told me to expect.
- Usman Tariq5 Jul 2026Rated 3.0 out of 5
The product is genuine but did not suit me personally. Customer service handled the return without any argument.
Reviews are from verified Hope Pharmacy orders. We do not remove a review for being critical.
What it is used for: Diabetes.
Indications as listed by the manufacturer: It is indicated as: - Initial therapy in patients with type 2 diabetes mellitus to improve glycemic control when diet and exercise do not provide adequate glycemic control. As an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus inadequately controlled on Metformin HCl or Sitagliptin alone or in patients already being treated with the combination of Sitagliptin and Metformin HCl.
How it works: By increasing and prolonging active incretin levels, Sitagliptin increases insulin release and decreases glucagon levels in the circulation in a glucose-dependent manner. It is a biguanide with antihyperglycemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycemia.
Active ingredient: Sitagliptin, Metformin.
Reported side effects: Common: nausea. Uncommon: somnolence, diarrhea, upper abdominal pain and blood glucose decreased.
Known drug interactions: Digoxin , Furosemide , Nifedipine , Cationic drugs (e.g., amiloride, digoxin, morphine, procainamide, quinidine, quinine ranitidine, triamterene, trimethoprim, or vancomycin) , thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.
- Sourced through authorised distributors and checked against batch and expiry on arrival
- Dispensed by a registered pharmacist from our DRAP-licensed branches
- Free pharmacist advice on interactions and timing — call or ask at checkout
- Same-day delivery in Karachi, Lahore and Islamabad on orders placed before 6pm
For patients with type 2 diabetes mellitus, whose hyperglycemic is inadequately controlled with diet and exercise alone, the recommended starting dose of (Sitagliptin + Metformin HCl) is 50mg of Sitagliptin + 500mg of Metformin HCl twice daily. Patients may be titrated upto 50mg Sitagliptin + 1000mg of Metformin HCl twice daily. The dosage of (Sitagliptin + Metformin HCl) should be individualized on the basis of patient’s current regimen, effectiveness and tolerability while not exceeding the maximum recommended daily dose of 100mg Sitagliptin.
Active ingredient: Sitagliptin, Metformin. Labelled strength: 50mg/500mg.
- The combination of Sitagliptin and Metformin HCl is contraindicated in:- Patients with type 1 diabetes. -Patients with known hypersensitivity to Sitagliptin, Metformin HCl or any other component of the product. - Acute or chronic metabolic acidosis , including ketoacidosis, with or without coma.
- Since impaired hepatic function has been associated with some cases of lactic acidosis, Sitagliptin+Metformin HCl should generally be avoided in patients with clinical or laboratory evidence of hepatic disease.
- Patient receiving Sitagliptin+Metformin HCl in combination with a sulphonylurea or with insulin may be at risk for hypoglycemia. Therefore, a reduction in the dose of the sulphonylurea or insulin may be necessary.
- After initiation of Sitagliptin, patients should be observed carefully for signs and symptoms of pancreatitis. If pancreatitis is suspected, Sitagliptin should promptly be discontinued and appropriate management should be initiated.
- Sitagliptin+Metformin HCl are known to be substantially excreted by the kidney. Metformin HCl-related lactic acidosis increases with the degree of insufficiency of renal function, therefore, serum creatinine concentrations should be determined regularly.
Store this medicine at room temperature, away from direct light and heat.
Manufactured by Gvia Healthcare (Pvt) Ltd.. Country of origin: Germany.
4.0
Rated 4.0 out of 51 verified ratings
- 5★0%
- 4★75%
- 3★25%
- 2★0%
- 1★0%
- Komal J.Verified Purchase4 Aug 2026Rated 4.0 out of 5
Rider was on time and the item was properly bubble-wrapped. No complaints.
- Fatima S.Verified Purchase24 Jul 2026Rated 4.0 out of 5
Rider was on time and the item was properly bubble-wrapped. No complaints.
- Imran Q.Verified Purchase9 Jul 2026Rated 4.0 out of 5
Works as expected. Took about three weeks to notice a difference, which the product page had already told me to expect.
- Usman Tariq5 Jul 2026Rated 3.0 out of 5
The product is genuine but did not suit me personally. Customer service handled the return without any argument.
Reviews are from verified Hope Pharmacy orders. We do not remove a review for being critical.
Frequently bought together
AbbottGvia M 50mg500mg TabletsRs. 1,815Rated 4.0 out of 5
StandpharmXiga 5mg Tablets 14sRs. 1,595Rated 4.5 out of 5
Martin DowAldactone Tablets 100mg 10sRs. 1,390Rated 4.5 out of 5
Bundle total
Rs. 4,800Rs. 5,445
Information on this site is for general guidance and is not a substitute for professional medical advice. Always consult your doctor or pharmacist.
You might also like
More in Medicine
